News Immunocore Holdings plc

Equities

IMCR

US45258D1054

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
54.25 ^USD	-3.14%		-11.53%	-20.59%

May. 13	Mizuho Cuts Price Target on Immunocore to $88 From $90, Keeps Buy Rating	MT
May. 08	Immunocore Holdings' Shares Fall After Q1 Net Loss Widens	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mizuho Cuts Price Target on Immunocore to $88 From $90, Keeps Buy Rating	May. 13	MT
Immunocore Holdings' Shares Fall After Q1 Net Loss Widens	May. 08	MT
Earnings Flash (IMCR) IMMUNOCORE HOLDINGS Reports Q1 Revenue $70.5M	May. 08	MT
Immunocore Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Immunocore reports first quarter financial results and provides a business update	May. 08	GL
Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	May. 01	AQ
Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target	Apr. 29	MT
Immunocore announces upcoming presentation and posters at ASCO 2024	Apr. 24	GL
Immunocore to present at upcoming investor conferences	Apr. 04	GL
Immunocore Holdings Files Mixed-Securities Shelf Registration	Mar. 21	MT
Transcript : Immunocore Holdings plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:30 AM	Mar. 14
Immunocore presented two posters at CROI 2024	Mar. 05	GL
Mizuho Securities Raises Immunocore Price Target to $90 From $86, Maintains Buy Rating	Mar. 04	MT
Immunocore to present at upcoming investor conferences	Mar. 01	GL
Oppenheimer Adjusts Immunocore Price Target to $87 From $85, Maintains Outperform Rating	Feb. 29	MT
Immunocore Holdings' Q4 Net Loss Narrows, Revenue Rises	Feb. 28	MT
Transcript : Immunocore Holdings plc, Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (IMCR) IMMUNOCORE HOLDINGS LIMITED Reports Q4 Revenue $70.2M, vs. Street Est of $68.5M	Feb. 28	MT
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update	Feb. 28	GL
Immunocore Holdings plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Immunocore Holdings plc

Equities

IMCR

US45258D1054

Summary

Filters